Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Current Medical Research and Opinion
|
December 29, 2015
Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder
Roger S McIntyre, Rana Fayyad, Joan A Mackell, et al.
International Journal of Cell Biology
|
February 5, 2010
Determinants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of beta-Adrenergic Receptors to Phosphoinositide 3-Kinase
Julie Simard, Matthieu Boucher, Rachel Massé, et al.
Expert Opinion on Pharmacotherapy
|
June 11, 2014
Desvenlafaxine for the treatment of major depressive disorder
Susan G Kornstein, Roger S McIntyre, Michael E Thase, et al.
Expert Opinion on Therapeutic Targets
|
September 2, 2025
Role of serotonin in the neurobiology of attention-deficit/hyperactivity disorder: a systematic literature review
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, et al.
Journal of Affective Disorders
|
April 2, 2017
Restoring function in major depressive disorder: A systematic review
David V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
Current Medical Research and Opinion
|
November 1, 2016
A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder
Michael Thase, Yuko Asami, Dalia Wajsbrot, et al.
Neuroscience and Biobehavioral Reviews
|
July 7, 2025
Role of serotonin in psychiatric and somatic comorbidities of attention-deficit/hyperactivity disorder: a systematic literature review
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, et al.
The Primary Care Companion for CNS Disorders
|
July 3, 2015
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
Roger S McIntyre, Rana S Fayyad, Christine J Guico-Pabia, et al.
The Primary Care Companion for CNS Disorders
|
December 9, 2015
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d
Roger S McIntyre, Rana S Fayyad, Christine J Guico-Pabia, et al.
Biological Psychiatry
|
October 6, 2005
Apoptosis detected in the amygdala following myocardial infarction in the rat
Boubacar Pasto Wann, Matthieu Boucher, Sevan Kaloustian, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Current Medical Research and Opinion
|
December 29, 2015
Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder
Roger S McIntyre, Rana Fayyad, Joan A Mackell, et al.
International Journal of Cell Biology
|
February 5, 2010
Determinants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of beta-Adrenergic Receptors to Phosphoinositide 3-Kinase
Julie Simard, Matthieu Boucher, Rachel Massé, et al.
Expert Opinion on Pharmacotherapy
|
June 11, 2014
Desvenlafaxine for the treatment of major depressive disorder
Susan G Kornstein, Roger S McIntyre, Michael E Thase, et al.
Expert Opinion on Therapeutic Targets
|
September 2, 2025
Role of serotonin in the neurobiology of attention-deficit/hyperactivity disorder: a systematic literature review
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, et al.
Journal of Affective Disorders
|
April 2, 2017
Restoring function in major depressive disorder: A systematic review
David V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
Current Medical Research and Opinion
|
November 1, 2016
A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder
Michael Thase, Yuko Asami, Dalia Wajsbrot, et al.
Neuroscience and Biobehavioral Reviews
|
July 7, 2025
Role of serotonin in psychiatric and somatic comorbidities of attention-deficit/hyperactivity disorder: a systematic literature review
Stephen V Faraone, Caroline L Ward, Matthieu Boucher, et al.
The Primary Care Companion for CNS Disorders
|
July 3, 2015
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
Roger S McIntyre, Rana S Fayyad, Christine J Guico-Pabia, et al.
The Primary Care Companion for CNS Disorders
|
December 9, 2015
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d
Roger S McIntyre, Rana S Fayyad, Christine J Guico-Pabia, et al.
Biological Psychiatry
|
October 6, 2005
Apoptosis detected in the amygdala following myocardial infarction in the rat
Boubacar Pasto Wann, Matthieu Boucher, Sevan Kaloustian, et al.
Page
of 5